LXMedical
A working demo · scripted data, careful by design

A breast molecular signature — research-use, reviewed by a physician.

LX Medical presents the MyBloodQ™ breast molecular signature — an investigational, Research Use Only molecular observation, clinician-mediated and independent of standard screening. It’s designed to start a conversation with a physician — never a diagnosis, never a screening result. This Stage-1 app does one thing well: you sign in, see your physician-reviewed result, and are guided, gently, on what comes next — with Aionic to read it carefully alongside you.

Clinic draw→physician review→your research observation→a conversation with your physician

The most careful surface we build

This is a cancer product, so every word is handled with care. The result is a research observation that points to a physician — not a verdict — and Aionic stays educational and calm throughout.

01
Research Use Only, not a diagnosisAn investigational molecular observation — a signature-enriched or reference-like pattern. It never says you do or don’t have cancer; only a physician, with further evaluation, can interpret it.
02
Physician-reviewed, physician-ledReviewed by a physician before you see it, and the clear next step is a conversation with them — with questions Aionic helps you prepare.
03
Standard-of-care independentIt doesn’t change your screening. Keep your mammograms and clinical exams on schedule, exactly as your physician advises.
04
Calm and DLI throughoutUnhurried, supportive, never alarming. The most emotionally careful experience in the platform.

Walk the demo

It opens at onboarding — sign in, enter the test ID from your provider, a gentle hand-off — then your Report, with Aionic to read it with you. (The blood draw happens in a clinic, so there’s no at-home kit here.) Use the Demo strip at the top of the app to step through, and to switch the result between a signature-enriched and a reference-like read.

Phone-first · the patient-facing view

Open the LX Medical app

Sign in → enter your test ID → a gentle hand-off → your Report. Then Care Path and Panels. Calm, careful, never a diagnosis — and Aionic is right there to walk it through.

Open the app →
On a phone? You'll go straight in. Live Aionic needs the deployed app (API keys server-side).
Desktop · clinician-facing · white-label (LX Medical)

Open the LX Medical Prospect Portal

The provider surface, white-labeled as LX Medical: enroll a prospect, generate the Test ID, track the draw, review the Aionic RUO research observation, add a note, and release it to the patient — the hard gate. Research Use Only · clinician-mediated.

Open the Console →
Desktop-first workstation. Mock data by default — open Spine (dev) in the rail to run the full loop end-to-end.
A working demo. All values, results and people are scripted and illustrative. The MyBloodQ™ breast molecular signature is Research Use Only — investigational, not for diagnostic use, not a screening result, and not medical advice.
Powered by Person Health